As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

On March 11, 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially declared a pandemic.

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

With all the different messages and information about the COVID-19 vaccine, you may be wondering whether your little one ...

The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Researchers have shown, for the first time, how the genetic material of the Nipah virus replicates in infected cells. The ...

Legislation aimed to ban or limit mRNA vaccines was introduced this year by GOP lawmakers in at least seven states.